R&D at other companies
Other financials
Where this comes from
Reported directly by Viemed Healthcare, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viemed Healthcare, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Viemed Healthcare, Inc.'s R&D?
- Viemed Healthcare, Inc. (VMD) reported R&D of $579K in Q1 2026.
- How has Viemed Healthcare, Inc.'s R&D changed year-over-year?
- Viemed Healthcare, Inc.'s R&D decreased by 27.4% year-over-year, from $797K to $579K.
- What is the long-term trend for Viemed Healthcare, Inc.'s R&D?
- Over 4 years (2021 to 2025), Viemed Healthcare, Inc.'s R&D has grown at a 9.4% compound annual growth rate (CAGR), from $2.11M to $3.02M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.